StonvexLoading…
StonvexStonvexStonvexCore line items from HLN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | £11.03B | £11.23B | £11.30B | £10.86B |
Operating Income | £2.41B | £2.21B | £2.00B | £1.82B |
Net Income | £1.68B | £1.48B | £1.11B | £1.12B |
EPS (Diluted) | £0.18 | £0.16 | £0.11 | £0.12 |
Total Assets | £32.63B | £34.31B | £34.05B | £34.81B |
Total Liabilities | £16.15B | £18.09B | £17.33B | £18.36B |
Cash & Equivalents | £1.32B | £2.25B | £1.04B | £684.00M |
Free Cash Flow OCF − CapEx | £2.31B | £2.05B | £1.87B | £1.76B |
Shares Outstanding | 8.95B | 9.08B | 9.23B | Not available |